Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

AGEN

Agenus (AGEN)

Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AGEN
DateTimeSourceHeadlineSymbolCompany
04/24/20237:30AMBusiness WireAgenus to Participate in May Investor ConferencesNASDAQ:AGENAgenus Inc
04/17/20237:30AMBusiness WireAgenus Receives Fast Track Designation for Botensilimab and Balstilimab in Colorectal CancerNASDAQ:AGENAgenus Inc
04/12/20234:30PMGlobeNewswire Inc.Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial OfficerNASDAQ:AGENAgenus Inc
04/03/20234:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
04/03/20234:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
04/03/20234:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
03/30/20239:26AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGENAgenus Inc
03/30/20238:41AMBusiness WireAgenus Announces Dividend of 5 Million Shares of MiNK TherapeuticsNASDAQ:AGENAgenus Inc
03/27/20239:45AMBusiness WireAgenus’ Botensilimab in Combination with Balstilimab Shows 33% Durable Responses in Ovarian CancerNASDAQ:AGENAgenus Inc
03/16/20234:56PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:AGENAgenus Inc
03/14/20237:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGENAgenus Inc
03/14/20237:30AMGlobeNewswire Inc.Agenus Reports Fourth Quarter and Full Year 2022 Financial Results and Outlines 2023 ObjectivesNASDAQ:AGENAgenus Inc
03/12/20238:29PMGlobeNewswire Inc.Agenus Cancels Conference Call to Discuss the Company’s Minority Cash Holdings at SVB in Light of Government’s SVB Deposit Access AnnouncementNASDAQ:AGENAgenus Inc
03/11/202311:24AMGlobeNewswire Inc.Agenus Schedules Conference Call to Discuss the Company’s Minority Cash Holdings at SVBNASDAQ:AGENAgenus Inc
02/28/20237:30AMGlobeNewswire Inc.Agenus to Present Botensilimab Data in Oral Plenary Session at the Society of Gynecologic Oncology 2023 Annual Meeting on Women’s CancerNASDAQ:AGENAgenus Inc
02/28/20237:30AMGlobeNewswire Inc.Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2022 Financial ReportNASDAQ:AGENAgenus Inc
02/09/202310:59AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AGENAgenus Inc
02/09/202310:16AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AGENAgenus Inc
02/03/20234:29PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AGENAgenus Inc
02/01/20234:31PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AGENAgenus Inc
01/26/20237:30AMGlobeNewswire Inc.Agenus to Participate in February Investor ConferencesNASDAQ:AGENAgenus Inc
01/23/20237:30AMGlobeNewswire Inc.Agenus Presents Clinical Data Demonstrating Durable Responses of Botensilimab/Balstilimab Combination in Metastatic Microsatellite Stable Colorectal Cancer at ASCO GINASDAQ:AGENAgenus Inc
01/10/20238:30AMGlobeNewswire Inc.Agenus to Participate at B Riley Securities’ 2023 Virtual Oncology ConferenceNASDAQ:AGENAgenus Inc
01/09/20236:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
01/09/20235:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
01/09/20235:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
01/04/202311:26AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
01/04/202311:21AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
01/04/202311:16AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AGENAgenus Inc
12/23/20224:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGENAgenus Inc
 Showing the most relevant articles for your search:NASDAQ:AGEN